SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-05-009317
Filing Date
2005-05-09
Accepted
2005-05-06 19:55:35
Documents
5
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a08662e10vq.htm 10-Q 233460
2 EXHIBIT 10.60 a08662exv10w60.txt EX-10.60 1474
3 EXHIBIT 31.1 a08662exv31w1.txt EX-31.1 4839
4 EXHIBIT 31.2 a08662exv31w2.txt EX-31.2 4827
5 EXHIBIT 32.1 a08662exv32w1.txt EX-32.1 2100
  Complete submission text file 0000950134-05-009317.txt   248106
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 05809605
SIC: 2836 Biological Products, (No Diagnostic Substances)